China Basal Cell Carcinoma Treatment Market Size & Outlook
China basal cell carcinoma treatment market, 2018-2030 (US$M)
Related Markets
China basal cell carcinoma treatment market highlights
- The China basal cell carcinoma treatment market generated a revenue of USD 108.1 million in 2023 and is expected to reach USD 260.0 million by 2030.
- The China market is expected to grow at a CAGR of 13.4% from 2024 to 2030.
- In terms of segment, surgery was the largest revenue generating type in 2023.
- Intralesional injections is the most lucrative type segment registering the fastest growth during the forecast period.
Basal cell carcinoma treatment market data book summary
| Market revenue in 2023 | USD 108.1 million |
| Market revenue in 2030 | USD 260.0 million |
| Growth rate | 13.4% (CAGR from 2023 to 2030) |
| Largest segment | Surgery |
| Fastest growing segment | Intralesional injections |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Radiotherapy (RT), Intralesional injections, Intravenous Medications, Chemical peeling treatment, Surgery, Topical chemotherapy, Oral Medications |
| Key market players worldwide | Bausch Health Companies Inc, Almirall SA, Genentech, Novartis AG ADR, Regeneron Pharmaceuticals Inc, Dr Reddy's Laboratories Ltd ADR, Taro Pharmaceuticals, Accord Healthcare |
Other key industry trends
- In terms of revenue, China accounted for 3.7% of the global basal cell carcinoma treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Australia basal cell carcinoma treatment market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 260.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Basal Cell Carcinoma Treatment Market Scope
Basal Cell Carcinoma Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China basal cell carcinoma treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to basal cell carcinoma treatment market will help companies and investors design strategic landscapes.
Surgery was the largest segment with a revenue share of 35.89% in 2023. Horizon Databook has segmented the China basal cell carcinoma treatment market based on radiotherapy (rt), intralesional injections, intravenous medications, chemical peeling treatment, surgery, topical chemotherapy, oral medications covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of the basal cell carcinoma treatment market in China can be attributed to several factors, reflecting the broader dynamics within the healthcare sector and the increasing focus on dermatological conditions.
The rising incidence of BCC among the Chinese population, as indicated by the occurrence rates among Chinese males and females, underscores a growing need for effective treatments.
China's aging population further amplifies this need, as older individuals are at a higher risk for developing skin cancers, including BCC. According to NIH, the prevalence of BCC in 100,000 individuals is 6.4 in Chinese males and 5.8 in Chinese females.
Reasons to subscribe to China basal cell carcinoma treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China basal cell carcinoma treatment market databook
-
Our clientele includes a mix of basal cell carcinoma treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China basal cell carcinoma treatment market , including forecasts for subscribers. This country databook contains high-level insights into China basal cell carcinoma treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China basal cell carcinoma treatment market size, by type, 2018-2030 (US$M)
China Basal Cell Carcinoma Treatment Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
